MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with F

Furosemide

Furosemide 20mg tablets

Use with caution

Stability notes for Furosemide 20mg tablets

Exposure of furosemide tablets to light may cause discoloration. Should be stored and dispensed in well-closed, light-resistant containers.

Provenance

This compatibility recommendation is derived from Furosemide 20mg tablets (Accord Healthcare Ltd).

Suppliers (13) of Furosemide 20mg tablets
Furosemide 20mg tablets (A A H Pharmaceuticals Ltd)
Furosemide 20mg tablets (Accord-UK Ltd)
Furosemide 20mg tablets (Alliance Healthcare (Distribution) Ltd)
Furosemide 20mg tablets (Almus Pharmaceuticals Ltd)
Furosemide 20mg tablets (Bristol Laboratories Ltd)
Furosemide 20mg tablets (Crescent Pharma Ltd)
Furosemide 20mg tablets (Ennogen Healthcare International Ltd)
Furosemide 20mg tablets (Genesis Pharmaceuticals Ltd)
Furosemide 20mg tablets (Ipca Laboratories UK Ltd)
Furosemide 20mg tablets (Medihealth (Northern) Ltd)
Furosemide 20mg tablets (Phoenix Healthcare Distribution Ltd)
Furosemide 20mg tablets (Relonchem Ltd)
Furosemide 20mg tablets (Sigma Pharmaceuticals Plc)

Furosemide 40mg tablets

Use with caution

Stability notes for Furosemide 40mg tablets

Exposure of furosemide tablets to light may cause discoloration. Should be stored and dispensed in well-closed, light-resistant containers.

Provenance

This compatibility recommendation is derived from Furosemide 40mg tablets (Accord Healthcare Ltd).

Suppliers (13) of Furosemide 40mg tablets
Furosemide 40mg tablets (A A H Pharmaceuticals Ltd)
Furosemide 40mg tablets (Accord-UK Ltd)
Furosemide 40mg tablets (Alliance Healthcare (Distribution) Ltd)
Furosemide 40mg tablets (Almus Pharmaceuticals Ltd)
Furosemide 40mg tablets (Bristol Laboratories Ltd)
Furosemide 40mg tablets (Crescent Pharma Ltd)
Furosemide 40mg tablets (Ennogen Healthcare International Ltd)
Furosemide 40mg tablets (Genesis Pharmaceuticals Ltd)
Furosemide 40mg tablets (Ipca Laboratories UK Ltd)
Furosemide 40mg tablets (Medihealth (Northern) Ltd)
Furosemide 40mg tablets (Phoenix Healthcare Distribution Ltd)
Furosemide 40mg tablets (Relonchem Ltd)
Furosemide 40mg tablets (Sigma Pharmaceuticals Plc)

Furosemide 500mg tablets

Use with caution

Stability notes for Furosemide 500mg tablets

Exposure of furosemide tablets to light may cause discoloration. Should be stored and dispensed in well-closed, light-resistant containers.

Provenance

This compatibility recommendation is derived from Furosemide 500mg tablets (Accord Healthcare Ltd).

Suppliers (6) of Furosemide 500mg tablets
Furosemide 500mg tablets (A A H Pharmaceuticals Ltd)
Furosemide 500mg tablets (Accord-UK Ltd)
Furosemide 500mg tablets (Alliance Healthcare (Distribution) Ltd)
Furosemide 500mg tablets (Ennogen Healthcare International Ltd)
Furosemide 500mg tablets (Medihealth (Northern) Ltd)
Furosemide 500mg tablets (Phoenix Healthcare Distribution Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.